stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) EPS (diluted)
Ingevity Corporation's EPS (diluted) for fiscal 2025 was −$4.61, compared with −$11.85 in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.47. Over the past ten years it has ranged from −$11.85 (fiscal 2024) to $5.50 (fiscal 2022); the current reading is higher than 18% of that period. Ingevity Corporation ranks 25th of 56 Specialty Chemicals companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$4.61 | — |
| FY2024 | −$11.85 | — |
| FY2023 | −$0.15 | — |
| FY2022 | $5.50 | 86.44% |
| FY2021 | $2.95 | (34.15%) |
| FY2020 | $4.48 | 2.99% |
| FY2019 | $4.35 | 9.57% |
| FY2018 | $3.97 | 33.67% |
| FY2017 | $2.97 | 257.83% |
| FY2016 | $0.83 | (58.55%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $1.00 | (39.76%) |
| Mar 2026 | $1.66 | — |
| Dec 2025 | −$2.37 | — |
| Sep 2025 | $1.18 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| WDFC WD-40 Company compare | $6.08 |
| IOSP Innospec Inc. compare | $5.66 |
| KWR Quaker Houghton compare | $5.59 |
| HWKN Hawkins, Inc. compare | $4.12 |
| FUL H. B. Fuller Company compare | $3.59 |
| NGVT Ingevity Corporation | $1.47 |
| CC The Chemours Company compare | −$1.02 |
| MTX Minerals Technologies Inc. compare | −$2.14 |
| STDN Standard Nuclear Inc compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on NGVT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement